.5 semaglutide not working 10 Reasons You're Losing Weight on 12 Reasons You're Not Losing

This is, to our knowledge, the first large multicenter study directly comparing GLP-1 receptor agonists and bariatric surgery in this population. Using the TriNetX research database, Patel and colleagues identified patients with BMI 30 kg/m 2 or greater who between 2016 and June 2025 had catheter ablation for AF and subsequently underwent bariatric surgery or initiated a GLP-1

Tirzepatide has shown promising results in promoting weight loss by improving insulin sensitivity and reducing appetite, making it a potential option for individuals struggling with obesity or being overweight

Its very exciting a really interesting new area for pharmacists to consider, and an important continuous-learning opportunity for pharmacists and pharmacy students

It includes oral options and coaching but requires a 12-month commitment and doesnt include labs